Conferences & Events

Found 92,183 articles

• Santhera and ReveraGen to Present Findings from Pivotal VISION-DMD Study with Vamorolone at Parent Project Muscular Dystrophy 2021 Conference

  6/24/2021

  Pratteln, Switzerland, and Rockville, MD, USA,June 24, 2021 – Santhera Pharmaceuticals and ReveraGen BioPharma, Inc announce presentations of the positive and statistically highly significant topline results from the VISION-DMD study at the Parent Project Muscular Dystrophy 2021 Virtual Annual Conference.

• ObsEva To Present Data on Two Clinical Development Programs at ESHRE Virtual 37th Annual Meeting

  6/24/2021

  ObsEva SA announced the presentation of data from two of its clinical development programs at the European Society of Human Reproduction and Embryology Virtual 37th Annual Meeting, being held June 26 - July 1, 2021.

• PolyPid Presents today at The Raymond James Human Health Innovation Conference

  6/23/2021

  PolyPid Ltd., a late-stage biopharma company aiming to improve surgical outcomes through locally administered, controlled, extended-release therapeutics, announced that Dikla Czaczkes Akselbrad, Executive Vice President and Chief Financial Officer will present at The Raymond James Human Health Innovation Conference at 9:20 am EDT.

• Apellis Pharmaceuticals to Host R&D Day on June 30, 2021

  6/23/2021

  Apellis Pharmaceuticals, Inc., a global biopharmaceutical company and leader in targeted C3 therapies, announced that the company will host a Research and Development Day from 12:30 p.m. to 4:30 p.m. ET on Wednesday, June 30, 2021 in New York City and virtually.

• Resverlogix Announces Voting Results from the 2021 Meeting of Shareholders

  6/23/2021

  Resverlogix Corp. held its Annual and Special Meeting of Shareholders in Calgary, Alberta.

• Lipocine Announces Presentations at The International Liver Congress™ 2021 Digital Event

  6/23/2021

  Lipocine Inc. today announced that clinical data will be presented at The International Liver Congress™ 2021, the annual meeting of the European Association for the Study of the Liver ("EASL"), Digital Event, on June 23-26 , 2021.

• SCYNEXIS to Present Commercial Launch Update for BREXAFEMME® (ibrexafungerp tablets)

  6/23/2021

  SCYNEXIS, Inc. today announced that it will present a commercial launch update for its recently FDA-approved drug, BREXAFEMME® (ibrexafungerp tablets).

• Cybin to Present at the Life Sciences Investor Forum on June 24th

  6/23/2021

  Cybin Inc.  today announced that Doug Drysdale, Chief Executive Officer, will be presenting at the Life Sciences Investor Forum on June 24, 2021.

• aTyr Pharma to Host Virtual Key Opinion Leader Event on Current Treatment Options for Pulmonary Sarcoidosis

  6/23/2021

  aTyr Pharma, Inc. today announced that the company will host a virtual Key Opinion Leader (KOL) event on the current treatment options for pulmonary sarcoidosis on Tuesday, June 29th at 5:00pm ET/2:00pm PT.

• Medtronic Announces Real-World Data on InPen™ and Extended Infusion Set* Pivotal Trial Data at the American Diabetes Association 81st Scientific Sessions

  6/23/2021

  Medtronic plc today announced its participation at the American Diabetes Association (ADA) 81th scientific sessions virtual meeting, June 25-29, 2021.

• Join Science 37 for a Panel of Health Industry Leaders Exploring “Decentralized Clinical Trials and the Empowered Patient Trial Experience” at Reuters Webinar

  6/23/2021

  Science 37 CEO David Coman alongside executives from Bayer, Sanofi, Merck and Pluto Health will discuss how to build an operating system to ensure patient preferences drive a decentralized clinical trial (DCT) approach during an upcoming Reuters Webinar. WHEN: Thursday, June 24, 2021 at 10:00 am ET.

• Mydecine to Participate in the ROTH Virtual Healthcare Private Company Forum on June 28th

  6/23/2021

  Mydecine Innovations Group today announced that Josh Bartch, CEO of Mydecine, will participate in the ROTH Healthcare Private Company Forum to be hosted virtually on Monday, June 28, 2021.

• Cytokinetics Announces Three Presentations to Occur at the European Society of Cardiology Heart Failure 2021 Congress

  6/23/2021

  Cytokinetics, Incorporated today announced three presentations at Heart Failure 2021, an International Congress of the European Society of Cardiology taking place online from June 29, 2021 – July 1, 2021.

• Alnylam to Host Eighth Annual “RNAi Roundtable” Webcast Series

  6/23/2021

  Alnylam Pharmaceuticals, Inc. , announced today that it plans to host its 8 th annual series of “RNAi Roundtable” webinars over the coming weeks.

• Adamas to Present at Upcoming SVB Leerink CNS Forum

  6/23/2021

  Adamas Pharmaceuticals, Inc. (Nasdaq: ADMS), a company dedicated to developing and delivering medicines that make a meaningful difference to people affected by neurological diseases, today announced that the company will present “What’s Happening in Parkinson’s Disease & the GOCOVRI Opportunity” at the SVB Leerink CNS Forum

• AGTC to Host Conference Call on June 24 at 8:00 AM ET to Discuss Achromatopsia 12-Month Data in its Ongoing CNGB3 and CNGA3 Phase 1/2 Clinical Trials

  6/23/2021

  Applied Genetic Technologies Corporation (Nasdaq: AGTC), a biotechnology company conducting human clinical trials of adeno-associated virus (AAV)-based gene therapies for the treatment of rare retinal diseases, today announced that it plans to release 12-month data for adult patients and low dose pediatric patients in its Phase 1/2 clinical Achromatopsia (ACHM) trials on Thursday, June 24, 2021.

• Axiom Presents "Case Study for Achieving Full Data Capture in a Pivotal Medical Device Study" at Clinical Trials for Medical Devices Virtual Conference

  6/23/2021

  Axiom Real-Time Metrics (“Axiom”), premier provider of unified eClinical solutions and services focused on small-to-medium life science organizations, will be exhibiting on June 23, 2021, at Clinical Trials for Medical Devices Virtual Conference

• Leading Liver Disease Researchers Present at EASL International Liver Congress™ 2021, Demonstrate Prognostic Value of Echosens’ FibroScan-based Agile Scores for Patients with Liver Disease

  6/23/2021

  Echosens, a high-technology company offering the FibroScan family of products, today announces that distinguished researchers will present studies supporting the value of FibroScan at EASL’s International Liver Congress, June 23-26, 2021.

• bioAffinity Technologies Presents Scientific Discoveries Advancing Cancer Therapeutics and Diagnostics at Two Global Conferences

  6/23/2021

  bioAffinity Technologies, a privately held biotech company, will present the Company’s discoveries in the field of cancer diagnostics and therapeutics at the RNA Therapeutics Institute’s 2021 RNA Therapeutics Symposium June 23 – 25, 2021, and the International Conference on Porphyrins and Phthalocyanines (ICPP) June 28 – July 3, 2021

• GENFIT presents new NIS4® data in NASH at the International Liver Congress™ and the 81st Scientific Sessions of the American Diabetes Association

  6/23/2021

  GENFIT (Nasdaq and Euronext: GNFT), a late-stage biopharmaceutical company dedicated to improving the lives of patients with metabolic and liver diseases, today announced it will be making two poster presentations at two internationally-renown scientific and medical events in June 2021, including a thought-leadership documentary featuring Key Opinion Leaders (KOLs).